Glenmark Pharmaceuticals submits media release

30 Aug 2019

Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Pimecrolimus Cream, 1%’, which is self-explanatory. 

The above information is a part of company’s filings submitted to BSE.

Related Glenmark Pharmaceuticals Ltd. Links:

Glenmark Pharma Share Price

335.45 -9.45 (-2.74%) Jan 29, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 450.05
Lupin 744.65
Dr. Reddys Lab 3148.60
Piramal Enterprises 1702.30
Cadila Healthcare 273.35
View more..
Sensex vs Glenmark Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463